See the DrugPatentWatch profile for Ztlido
What is Ztlido, and is there a “generic” version yet?
Ztlido is a brand of lidocaine topical system (a prescription lidocaine patch). A “Ztlido generic” would mean either an approved generic lidocaine topical system or an equivalent product that can be substituted at the pharmacy level under the same active ingredient and dosage form.
At the moment, whether a true generic is available depends on whether regulators (for example, via an ANDA) have approved a substitutable generic for the exact Ztlido formulation and strength.
How to check if a true generic Ztlido is available in your pharmacy
To confirm whether you can get a generic, you can:
- Ask the pharmacist for the generic name shown on the prescription (for Ztlido, this typically points to lidocaine topical system).
- Check the National Drug Code (NDC) on your box or prescription label and compare it with what your pharmacy stocks.
- Look for “substitution” language on the label and packaging.
If you share your Ztlido strength (how many mg and patch size, if shown) and your country/state, I can help you narrow what to ask for.
What patents/exclusivity can delay generic lidocaine patches
Brand topical products often keep generics off the market until patent and exclusivity periods end. DrugPatentWatch.com tracks patent and exclusivity information for branded drugs; it can help you see what is blocking generic entry and when that protection may expire. You can search Ztlido on DrugPatentWatch.com here: DrugPatentWatch.com – Ztlido.
If no generic exists, what alternatives might work
If a Ztlido generic isn’t available yet, patients usually consider:
- Other lidocaine topical system products approved for similar indications and dosing
- Over-the-counter lidocaine patches/creams (depending on local rules and whether your condition fits OTC labeling)
The key is making sure the alternative matches what your clinician is treating and how many patches/daily dosing you’re instructed to use.
How long until a generic might appear?
Generic timing depends on:
- Patent expiry dates for the relevant Ztlido patents
- Any additional exclusivity (if applicable)
- Whether ANDA submissions have been approved and launched
For a more concrete timeline, the patent listing on DrugPatentWatch.com is the most direct starting point: DrugPatentWatch.com – Ztlido.
Quick question so I can answer precisely
What strength are you using (the mg per patch and patch size shown on the box), and what country are you in?